Structure-Function Studies and Mechanism of Action of Snake Venom L-Amino Acid Oxidases.
Journal: 2020/March - Frontiers in Pharmacology
ISSN: 1663-9812
Abstract:
Snake venom L-amino acid oxidases (SV-LAAOs) are the least studied venom enzymes. These enzymes catalyze the stereospecific oxidation of an L-amino acid to their corresponding α-keto acid with the liberation of hydrogen peroxide (H2O2) and ammonia (NH3). They display various pathological and physiological activities including induction of apoptosis, edema, platelet aggregation/inhibition, hemorrhagic, and anticoagulant activities. They also show antibacterial, antiviral and leishmanicidal activity and have been used as therapeutic agents in some disease conditions like cancer and anti-HIV drugs. Although the crystal structures of six SV-LAAOs are present in the Protein Data Bank (PDB), there is no single article that describes all of them in particular. To better understand their structural properties and correlate it with their function, the current work describes structure characterization, structure-based mechanism of catalysis, inhibition and substrate specificity of SV-LAAOs. Sequence analysis indicates a high sequence identity (>84%) among SV-LAAOs, comparatively lower sequence identity with Pig kidney D-amino acid oxidase (<50%) and very low sequence identity (<24%) with bacterial LAAOs, Fugal (L-lysine oxidase), and Zea mays Polyamine oxidase (PAAO). The three-dimensional structure of these enzymes are composed of three-domains, a FAD-binding domain, a substrate-binding domain and a helical domain. The sequence and structural analysis indicate that the amino acid residues in the loops vary in length and composition due to which the surface charge distribution also varies that may impart variable substrate specificity to these enzymes. The active site cavity volume and its average depth also vary in these enzymes. The inhibition of these enzymes by synthetic inhibitors will lead to the production of more potent antivenoms against snakebite envenomation.
Relations:
Content
Citations
(3)
Diseases
(1)
Conditions
(1)
Drugs
(4)
Chemicals
(9)
Organisms
(1)
Processes
(5)
Anatomy
(1)
Similar articles
Articles by the same authors
Discussion board
Front Pharmacol 11: 110

Structure–Function Studies and Mechanism of Action of Snake Venom L-Amino Acid Oxidases

Click here for additional data file.(1.7M, docx)
Department of Biosciences, COMSATS University Islamabad, Islamabad, Pakistan,
Edited by: Jean-Marc Sabatier, UMR7051 Institut de Neurophysiopathologie, France
Reviewed by: Andreimar Martins Soares, Fiocruz Rondonia, Brazil; Ayobami Matthew Olajuyin, Henan Provincial People's Hospital, China; Carlos Chavez Olortegui, Federal University of Minas Gerais, Brazil
*Correspondence: Anwar Ullah, moc.oohay@09sm.rawna; kp.ude.stasmoc@hallurawna
This article was submitted to Pharmacology of Ion Channels and Channelopathies, a section of the journal Frontiers in Pharmacology
Edited by: Jean-Marc Sabatier, UMR7051 Institut de Neurophysiopathologie, France
Reviewed by: Andreimar Martins Soares, Fiocruz Rondonia, Brazil; Ayobami Matthew Olajuyin, Henan Provincial People's Hospital, China; Carlos Chavez Olortegui, Federal University of Minas Gerais, Brazil
Received 2019 Oct 16; Accepted 2020 Jan 28.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Abstract

Snake venom L-amino acid oxidases (SV-LAAOs) are the least studied venom enzymes. These enzymes catalyze the stereospecific oxidation of an L-amino acid to their corresponding α-keto acid with the liberation of hydrogen peroxide (H2O2) and ammonia (NH3). They display various pathological and physiological activities including induction of apoptosis, edema, platelet aggregation/inhibition, hemorrhagic, and anticoagulant activities. They also show antibacterial, antiviral and leishmanicidal activity and have been used as therapeutic agents in some disease conditions like cancer and anti-HIV drugs. Although the crystal structures of six SV-LAAOs are present in the Protein Data Bank (PDB), there is no single article that describes all of them in particular. To better understand their structural properties and correlate it with their function, the current work describes structure characterization, structure-based mechanism of catalysis, inhibition and substrate specificity of SV-LAAOs. Sequence analysis indicates a high sequence identity (>84%) among SV-LAAOs, comparatively lower sequence identity with Pig kidney D-amino acid oxidase (<50%) and very low sequence identity (<24%) with bacterial LAAOs, Fugal (L-lysine oxidase), and Zea mays Polyamine oxidase (PAAO). The three-dimensional structure of these enzymes are composed of three-domains, a FAD-binding domain, a substrate-binding domain and a helical domain. The sequence and structural analysis indicate that the amino acid residues in the loops vary in length and composition due to which the surface charge distribution also varies that may impart variable substrate specificity to these enzymes. The active site cavity volume and its average depth also vary in these enzymes. The inhibition of these enzymes by synthetic inhibitors will lead to the production of more potent antivenoms against snakebite envenomation.

Keywords: snake venom L-amino acid oxidases, sequence and three-dimensional structure analysis, structure-based mechanism of action, inhibition and substrate specificity, L-amino acid oxidases and membrane interaction
Abstract
Click here for additional data file.(1.7M, docx)
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.